Rigel Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report

Rigel Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Rigel Pharmaceuticals, Inc. (Rigel or 'the company') is a clinical-stage drug development company that commercializes and sells novel, targeted drugs in immunology, inflammatory, autoimmune, oncology and immuno-oncology related therapeutic areas. It conducts various clinical trails and receives approval from the US Food and Drug Administration (FDA) before implementing on various patients. In addition, it collaborates with various pharmaceutical companies for developing therapeutic drugs. The company is headquartered in South San Francisco, California, the US.

Scope

– Detailed information on Rigel Pharmaceuticals, Inc. required for business and competitor intelligence needs

– A study of the major internal and external factors affecting Rigel Pharmaceuticals, Inc. in the form of a SWOT analysis

– An in-depth view of the business model of Rigel Pharmaceuticals, Inc. including a breakdown and examination of key business segments

– Intelligence on Rigel Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about Rigel Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Rigel Pharmaceuticals, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Rigel Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Rigel Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Table of Contents

Rigel Pharmaceuticals, Inc.: Company Overview

Rigel Pharmaceuticals, Inc.: Overview and Key Facts

Rigel Pharmaceuticals, Inc.: Overview

Rigel Pharmaceuticals, Inc.: Key Facts

Rigel Pharmaceuticals, Inc.: Key Employees

Rigel Pharmaceuticals, Inc.: Key Employee Biographies

Rigel Pharmaceuticals, Inc.: Major Products and Services

Rigel Pharmaceuticals, Inc.: Company History

Rigel Pharmaceuticals, Inc.: Management Statement

Rigel Pharmaceuticals, Inc.: Locations and Subsidiaries

Rigel Pharmaceuticals, Inc.: Key Competitors

Rigel Pharmaceuticals, Inc.: Company Analysis

Rigel Pharmaceuticals, Inc.: Business Description

Rigel Pharmaceuticals, Inc.: SWOT Analysis

Rigel Pharmaceuticals, Inc.: SWOT Overview

Rigel Pharmaceuticals, Inc.: Strengths

Rigel Pharmaceuticals, Inc.: Weaknesses

Rigel Pharmaceuticals, Inc.: Opportunities

Rigel Pharmaceuticals, Inc.: Threats

Rigel Pharmaceuticals, Inc.: Corporate Financial Deals Activity

Rigel Pharmaceuticals, Inc.: Financial Deals Overview

Rigel Pharmaceuticals, Inc.: Targets and Partners

Rigel Pharmaceuticals, Inc.: Top Deals 2016 - 2020YTD*

Rigel Pharmaceuticals, Inc.: Advisors

Rigel Pharmaceuticals, Inc.: Top Legal Advisors

Rigel Pharmaceuticals, Inc.: Top Financial Advisors

Rigel Pharmaceuticals, Inc.: Capital Raising

Rigel Pharmaceuticals, Inc.: Partnership

Rigel Pharmaceuticals, Inc.: Recent Developments

Rigel Pharmaceuticals, Inc.: News and Events Summary

Rigel Pharmaceuticals, Inc.: Corporate Governance

Rigel Pharmaceuticals, Inc.: Financial Performance

Rigel Pharmaceuticals, Inc.: Market Developments

Rigel Pharmaceuticals, Inc.: Research & Development

Rigel Pharmaceuticals, Inc.: Strategy and Operations

Appendix

Contact Us

Methodology

About MarketLine

List of Tables

List of Tables

Table 1: Rigel Pharmaceuticals, Inc.: Key Facts

Table 2: Rigel Pharmaceuticals, Inc.: Key Employees

Table 3: Rigel Pharmaceuticals, Inc.: Company History

Table 4: Rigel Pharmaceuticals, Inc.: Locations and Subsidiaries

Table 5: Rigel Pharmaceuticals, Inc.: Key Competitors

Table 6: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type – Volume (2016 – YTD*2020)

Table 7: Rigel Pharmaceuticals, Inc.: Targets and Partners

Table 8: Rigel Pharmaceuticals, Inc.: Top Deals 2016 – 2020YTD*

Table 9: Rigel Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)

Table 10: Rigel Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)

Table 11: Rigel Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2016 – YTD*2020)

Table 12: Rigel Pharmaceuticals, Inc.: Capital Raising by Deal Type (2016 – YTD*2020)

Table 13: Rigel Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2016 – YTD*2020)

Table 14: Rigel Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2016 – YTD*2020)

Table 15: Rigel Pharmaceuticals, Inc.: News and Events Summary

Table 16: Rigel Pharmaceuticals, Inc.: Corporate Governance

Table 17: Rigel Pharmaceuticals, Inc.: Financial Performance

Table 18: Rigel Pharmaceuticals, Inc.: Market Developments

Table 19: Rigel Pharmaceuticals, Inc.: Research & Development

Table 20: Rigel Pharmaceuticals, Inc.: Strategy and Operations

List of Figures

List of Figures

Figure 1: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type – Volume (2016 – YTD*2020)

Figure 2: Rigel Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2016 – YTD*2020)

Figure 3: Rigel Pharmaceuticals, Inc.: Capital Raising by Deal Type (2016 – YTD*2020)

Figure 4: Rigel Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2016 – YTD*2020)

Figure 5: Rigel Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2016 – YTD*2020)

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports